|Bid||129.98 x 700|
|Ask||131.14 x 600|
|Day's Range||130.29 - 130.95|
|52 Week Range||106.87 - 131.92|
|PE Ratio (TTM)||64.33|
|Expense Ratio (net)||0.06%|
The proton therapy market is a highly lucrative opportunity area for Varian Medical Systems (VAR). Proton therapy uses protons for treating cancer instead of X-rays. According to a Medgadget report,…
In 2Q17, Celgene’s (CELG) Otezla generated revenues of around $358 million, which reflected ~49% growth on a year-over-year basis.
For fiscal 1Q18, Kors's EPS came in at $0.90, or $0.28 higher than the estimate. Its revenue fell 3.6% YoY to $952 million but still beat the consensus estimate.